January 2, 2018 / 2:40 PM / 10 months ago

BRIEF-Sucampo Pharmaceuticals Received Notification From FDA That It Has Extended PDUFA Goal Date By 3 Months

Jan 2 (Reuters) - Sucampo Pharmaceuticals Inc:

* SUCAMPO PHARMACEUTICALS - ON DEC 28, RECEIVED NOTIFICATION FROM U.S. FDA THAT IT HAS EXTENDED PDUFA GOAL DATE BY 3 MONTHS FOR SNDA FOR LUBIPROSTONE

* SUCAMPO PHARMACEUTICALS - EXTENDED USER FEE GOAL DATE FOR THE SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR LUBIPROSTONE IS APRIL 28, 2018- SEC FILING Source text :[bit.ly/2Ctygjm] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below